EX-FILING FEES 6 ny20006674x4_ex107.htm FILING FEES TABLE

 

 

Exhibit 107

 

CALCULATION OF FILING FEE TABLE

 

FORM S-4 

(Form Type) 

ANGION BIOMEDICA CORP. 

(Exact Name of Registrant as Specified in its Charter)

 

Table I: Newly Registered and Carry Forward Securities

Security
Type		 Security
Class
Title		 Fee
Calculation
or Carry
Forward
Rule		 Amount
Registered1		 Proposed
Maximum
Offering
Price Per
Unit		 Maximum
Offering Price		 Fee Rate Amount of
Registration
Fee
Equity Common Stock, par value $0.01 per share 457(c), 457(f)(1) 57,192,2302 $0.71 $40,606,483.303 0.0001102 $4,474.84
Total Offering Amounts
$40,606,483.30
  
$4,474.84
Total Fees Previously Paid       —
Total Fee Offsets       —
Net Fee Due      
$4,474.84

 

 

1 Pursuant to Rule 416(a) of the U.S. Securities Act of 1933, as amended (the “Securities Act”), there are also being registered an indeterminable number of additional securities as may be issued to prevent dilution resulting from share splits, share dividends or similar transactions. 

2 Based on the maximum number of Common Stock, par value $0.01 per share (Angion Common Stock), of Angion Biomedica Corp. (Angion) estimated to be issued in connection with the Merger described herein (the Merger) between Angion, Arkham Merger Sub Inc. (Merger Sub), and Elicio Therapeutics Inc. (Elicio). 

3 Pursuant to Rules 457(c) and 457(f)(1) promulgated under the Securities Act and solely for the purpose of calculating the registration fee, the proposed maximum aggregate offering price is calculated as the product of (i) 57,192,230 Angion Common Stock and (ii) $0.71, the average of the high and low trading prices of the Angion Common Stock on February 9, 2023 (within five business days prior to the date of this registration statement).

 

The Registrant does not have any carry-forward securities.